Hong Seng Consolidated is to take stakes in Neogenix Laboratoire and eMedAsia for a combined M$9.5m (US$2.4m) as the conglomerate expands its healthcare business. The investment holding company, previously known as MSCM Holdings, is to buy a 60% stake in Selangor-based diagnostics group Neogenix Laboratoire for M$6.5m. Neogenix is a medical diagnostic and research laboratory…
©2023 All rights reserved LaingBuisson 
){kind=link}